Indiana’s life sciences industry breaks yearly records in two key categories – exports and venture capital
INDIANAPOLIS, (March 25, 2021) -- While COVID-19 continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing but remained committed to innovating and investing throughout 2020. New data provided to BioCrossroads by the Indiana Business Research Center (IBRC) at the Indiana University Kelley School of Business shows a thriving and growing sector. One of the most notable milestones: Indiana is the second highest exporter of life sciences products in the U.S. and has been for more than a decade. In 2020, more than $11.4 billion of products were exported from the state, representing more than $192,000 of output per worker, the highest amount ever recorded. In addition, Indiana life sciences start-ups garnered a record level of venture capital investment with more than $262 million committed to 44 companies, [...]